[1]陈晓珍,李一飞,张璇,等.脂肪细胞谷氨酰胺合成酶抑制结肠癌细胞的腹腔转移及血管生成[J].第三军医大学学报,2018,40(01):70-75.
　CHEN Xiaozhen,LI Yifei,ZHANG Xuan,et al.Glutamine synthetase from adipocytes inhibits peritoneal metastasis and angiogenesis of colon cancer in mice[J].J Third Mil Med Univ,2018,40(01):70-75.
点击复制

脂肪细胞谷氨酰胺合成酶抑制结肠癌细胞的腹腔转移及血管生成(/HTML )
分享到：

《第三军医大学学报》[ISSN:1000-5404/CN:51-1095/R]

卷:
40卷
期数:
2018年第01期
页码:
70-75
栏目:
基础医学
出版日期:
2018-01-15

文章信息/Info

Title:
Glutamine synthetase from adipocytes inhibits peritoneal metastasis and angiogenesis of colon cancer in mice
作者:
陈晓珍; 李一飞; 张璇; 缪洪明; 梁后杰
第三军医大学西南医院肿瘤科
Author(s):
CHEN Xiaozhen;  LI Yifei;  ZHANG Xuan;  MIAO Hongming;  LIANG Houjie

Department of Oncology,Southwest Hospital,Third Military Medical University,Chongqing,400038,China

关键词:
脂肪细胞谷氨酰胺合成酶; 血管生成; 结肠癌; 腹腔转移
Keywords:
glutamine synthetase; adipocytes;  angiogenesis;  colon cancer;  peritoneal metastasis
分类号:
R345; R730-37; R735.35
文献标志码:
A
摘要:

目的     探讨脂肪细胞谷氨酰胺合成酶（glutamine synthetase,GS）对结肠癌腹腔转移及血管生成的影响。方法    转基因小鼠的鉴定：Western blot检测野生型（WT）小鼠及脂肪细胞GS转基因(TgGS)小鼠脂肪细胞GS蛋白的表达。体内实验：分别构建WT小鼠及TgGS小鼠的腹腔转移模型，观察结肠癌细胞在腹腔的种植情况；免疫组化检测移植瘤的血管生成情况。体外实验：取WT及TgGS小鼠的脂肪进行无菌培养，收集条件培养基；通过小管形成实验、CCK8实验、Transwell实验观察条件培养基对人脐静脉内皮细胞（human umbilical vein endothelial cells, HUVECs）的小管形成、增殖及迁移的影响。结果    Western blot检测结果显示，TgGS小鼠较WT小鼠脂肪细胞GS蛋白水平显著上调（P<0.05）。TgGS小鼠较WT小鼠腹腔移植瘤数量明显减少[（6.33±4.04） vs （16.00±6.56）,P<0.05]，体积明显减小[（2.35±1.93） vs （9.37±5.07）,P<0.01]。免疫组化结果显示，TgGS小鼠肿瘤血管生成明显少于WT小鼠（P<0.05）。体外小管形成实验显示TgGS组较WT组HUVECs小管形成总长度明显缩短（P<0.05）；CCK8实验显示TgGS组及WT组HUVECs的增殖差异无统计学意义（P>0.05）；Transwell实验显示TgGS组HUVECs细胞迁移数量明显少于WT组[（15.33±5.50） vs （78.33±13.58），P<0.01]。结论    脂肪细胞GS可抑制结肠癌腹腔转移及肿瘤血管生成。

Abstract:

Objective    To determine the effect of glutamine synthetase (GS) derived from adipocytes on intraperitoneal metastasis and angiogenesis of colon cancer. Methods     Wide type(WT)and transgenetic mice (TgGS) were firstly identified with Western blotting for the expression level of GS protein in the adipocytes.Then mouse model of peritoneal metastasis of colon cancer MC38 cells was established by intraperitoneally injecting 2.0×106 cells in the WT mice and TgGS mice. Then the cell implantation and tumor formation were observed.Immunohistochemical assay was used to detect the angiogenesis of the tumor mass.The fat tissues were harvested from WT and TgGS mice,and then the adipocytes were isolated and cultured to obtain the 2 kinds of adipocyte conditional media.Then tube formation assay, CCK8 assay, and Transwell chamber test were used to determine the effects of the 2 kinds of conditioned media on the tube formation, proliferation and migration in human umbilical vein endothelial cells (HUVECs). Results    Western blotting showed that the expression level of GS protein in the adipocytes of TgGS mice was significantly increased than that in WT mice (P<0.05). In the xenograft model, there were notably less (6.33±4.04 vs 16.00±6.56,P<0.05) and smaller(2.35±1.93 vs 9.37±5.07, P<0.01) tumors in the TgGS mice when compared with the WT mice. Immunohistochemical assay showed that the angiogenesis in TgGS mice were obviously less than that in WT mice(P<0.05).The tube formation assay indicated that the total lengths of tubules was significantly shorter in the HUVECs co-cultured with adipocyte conditional medium from the TgGSmice than those with the medium from the WT mice group (P<0.05). CCK8 assay displayed that there was no significant difference in the cell proliferation of HUVECs between the 2 kinds of media (P>0.05).Transwell chamber test showed that there were less migrated cells in the HUVECs with TgGS culture medium than those with WT culture medium (15.33±5.50 vs 78.33±13.58, P<0.01). Conclusion    Adipocyte GS can inhibits peritoneal metastasis  and tumor angiogenesis of colon cancer.

参考文献/References:

[1]LEMOINE L, SUGARBAKER P, VAN DER SPEETEN K. Pathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneum[J]. World J Gastroenterol, 2016, 22(34): 7692-7707.DOI:10.3748/wjg.v22.i34.7692.
[2]ARJONA-S-NCHEZ A, MEDINA-FERN-NDEZ F J, MU-OZ-CASARES F C, et al. Peritoneal metastases of colorectal origin treated by cytoreduction and HIPEC: An overview[J]. World J Gastrointest Oncol, 2014, 6(10): 407-412.DOI:10.4251/wjgo.v6.i10.407.
[3]SIEGEL R, DESANTIS C, JEMAL A. Colorectal cancer statistics, 2014[J]. CA Cancer J Clin, 2014, 64(2): 104-117.DOI:10.3322/caac.21220.
[4]KIANMANESH R, SCARINGI S, SABATE J M, et al. Iterative cytoreductive surgery associated with hyperthermic intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis of colorectal origin with or without liver metastases[J]. Ann Surg, 2007, 245(4): 597-603.DOI:10.1097/01.sla.0000255561.87771.11.
[5]AOYAGI T. Current treatment options for colon cancer peritoneal carcinomatosis[J]. World J Gastroenterol, 2014, 20(35): 12493.DOI:10.3748/wjg.v20.i35.12493.
[6]EASSON A M, BEZJAK A, ROSS S, et al. The ability of existing questionnaires to measure symptom change after paracentesis for symptomatic ascites.[J]. Ann Surg Oncol, 2007, 14(8): 2348-2357.DOI:10.1245/s10434-007-9370-3.
[7]PASSOT G, BAKRIN N, ROUX A S, et al. Quality of life after cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy: A prospective study of 216 patients[J]. Eur J Surg Oncol, 2014, 40(5): 529-535.DOI:10.1016/j.ejso.2013.11.019.
[8]SHANG F T, HUI L L, AN X S, et al. ZnPPIX inhibits peritoneal metastasis of gastric cancer via its antiangiogenic activity[J]. Biomed Pharmacother, 2015, 71: 240-246.DOI:10.1016/j.biopha.2015.03.005.
[9]ACKERMAN D, SIMON M C. Hypoxia, lipids, and cancer: surviving the harsh tumor microenvironment[J]. Trends Cell Biol, 2014, 24(8): 472-478.DOI:10.1016/j.tcb.2014.06.001.
[10]MIAO H, OU J, PENG Y, et al. Macrophage ABHD5 promotes colorectal cancer growth by suppressing spermidine production by SRM[J]. Nat Commun, 2016, 7: 11716.DOI:10.1038/ncomms11716.
[11]ROSE C F, VERKHRATSKY A, PARPURA V. Astrocyte glutamine synthetase: pivotal in health and disease[J]. Biochem Soc Trans, 2013, 41(6): 1518-1524.DOI:10.1042/BST20130237.
[12]BOTT A J, PENG I C, FAN Y, et al. Oncogenic Myc Induces Expression of Glutamine Synthetase through Promoter Demethylation[J]. Cell Metab, 2015, 22(6): 1068-1077.DOI:10.1016/j.cmet.2015.09.025.
[13]WU Q J, GONG C Y, LUO S T, et al. AAV-mediated human PEDF inhibits tumor growth and metastasis in murine colorectal peritoneal carcinomatosis model[J]. BMC Cancer, 2012, 12(1): 129.DOI:10.1186/1471-2407-12-129.
[14]CARMELIET P, JAIN R K. Molecular mechanisms and clinical applications of angiogenesis[J]. Nature, 2011, 473(7347): 298-307.DOI:10.1038/nature10144.
[15]MABETA P. Inhibition of phosphoinositide 3-kinase is associated with reduced angiogenesis and an altered expression of angiogenic markers in endothelioma cells[J]. Biomed Pharmacother, 2014, 68(5): 611-617.DOI:10.1016/j.biopha.2014.03.017.
[16]NIEMAN K M, KENNY H A, PENICKA C V, et al. Adipocytes promote ovarian cancer metastasis and provide energy for rapid tumor growth[J]. Nat Med, 2011, 17(11): 1498-1503. DOI:10.1038/nm.2492.
[17]GREEN C R, WALLACE M, DIVAKARUNI A S, et al. Branched-chain amino acid catabolism fuels adipocyte differentiation and lipogenesis[J]. Nat Chem Biol, 2016, 12(1): 15-21.DOI:10.1038/nchembio.1961.
[18]李一飞,陈晓珍,张璇,等.脂肪细胞谷氨酰胺合成酶抑制结肠癌细胞的肝、肺转移[J].第三军医大学学报, 2017, 39(23): 2255-2262. DOI: 10.16016/j.10005404.201707147.
LI Y F, CHEN X Z, ZHANG X, et al. Glutamine synthetase from adipocytes inhibits hepatic and pulmonary metastasis of colon cancer cells[J]. J Third Mil Med Univ, 2017, 39(23): 2255-2262. DOI: 10.16016/j.1000-5404.201707147.
[19]LU W, PELICANO H, HUANG P. Cancer metabolism: is glutamine sweeter than glucose?[J]. Cancer Cell, 2010, 18(3): 199-200.DOI:10.1016/j.ccr.2010.08.017.
[20]WANG J B, ERICKSON J W, FUJI R, et al. Targeting mitochondrial glutaminase activity inhibits oncogenic transformation[J]. Cancer Cell, 2010, 18(3): 207-219.DOI:10.1016/j.ccr.2010.08.009.
[21]李芬，肖新华. 脂肪组织的微循环[J]. 国际病理科学与临床杂志, 2011, 31(5): 394-397.DOI：10.3969/j.issn.1673-2588.2011.10.006.
LI F,XIAO X F.Microcirculation of adipose tissue[J].Int J Pathol Clin Med,2011, 31(5): 394-397.DOI：10.3969/j.issn.1673-2588.2011.10.006.
[22]COOK K M, FIGG W D. Angiogenesis inhibitors: current strategies and future prospects[J]. CA Cancer J Clin, 2010, 60(4): 222-243.DOI:10.3322/caac.20075.
[23]CURI R, LAGRANHA C J, DOI S Q, et al. Molecular mechanisms of glutamine action[J]. J Cell Physiol, 2005, 204(2): 392-401.DOI:10.1002/jcp.20339.

相似文献/References:

[1]莫贵艳,李敏,胡成平,等.茶氨酸对内皮细胞生长及肺癌血管生成的影响[J].第三军医大学学报,2012,34(20):2043.
　Mo Guiyan,Li Min,Hu Chengping,et al.Theanine suppresses angiogenesis of endothelial cells in vitro and in vivo[J].J Third Mil Med Univ,2012,34(01):2043.
[2]张庆勇,陈燕萍,刘芬,等.人参皂苷Rg1对大鼠急性缺血心肌血管再生的促进作用[J].第三军医大学学报,2013,35(01):42.
　Zhang Qingyong,Chen Yanping,Liu Fen,et al.Ginsenoside-Rg1 promotes angiogenesis in rats with acute myocardial ischemia[J].J Third Mil Med Univ,2013,35(01):42.
[3]王清良,卞修武,蒋雪峰,等.计算机辅助的人脑间变性星形细胞瘤微血管构筑三维重建[J].第三军医大学学报,2006,28(11):1148.
[4]党涛,卞修武,赵雯,等.VEGF诱导人脐静脉内皮细胞体外三维成型和对EphrinB2/EphB4表达的影响[J].第三军医大学学报,2006,28(10):1077.
[5]吴晋蓉,曾发贵,王清良,等.定量分析人脑星形细胞肿瘤组织芯片中血管生成与肿瘤微血管结构[J].第三军医大学学报,2006,28(10):1090.
[6]王清良,卞修武,章容,等.人脑星形细胞肿瘤微血管组织芯片的构建[J].第三军医大学学报,2006,28(09):886.
[7]文雪,易永芬,邓玮,等.shRNA抑制p115表达对胃癌体外血管形成的影响[J].第三军医大学学报,2011,33(16):1676.
　Wen Xue,Yi Yongfen,Deng Wei,et al.Influence of shRNA-mediated p115 gene silencing on angiogenesis in gastric cancer cells in vitro[J].J Third Mil Med Univ,2011,33(01):1676.
[8]仲召阳,王东,李增鹏,等.骨肉瘤中APE1的表达及其与血管生成的关系[J].第三军医大学学报,2005,27(10):1045.
[9]蒋雪峰,卞修武,王清良,等.人脑恶性胶质瘤微血管内皮细胞的分离培养与体外血管生成特性[J].第三军医大学学报,2005,27(04):291.
[10]程绍钧,李前伟,李忠俊,等.以血管生成为靶点的肿瘤核素显像及治疗的实验研究[J].第三军医大学学报,2005,27(02):109.

更新日期/Last Update: 2018-01-12